Loading candles…
Natural Capsules, incorporated in 1993, is an Indian company specializing in the manufacture of capsules and related products. It produces hard capsule shells made from gelatin and vegetarian HPMC materials, as well as steroidal active pharmaceutical ingredients (APIs) and their intermediates and derivatives. Serving the pharmaceutical and dietary supplement industries, Natural Capsules provides delivery systems for various formulations. The company is recognized as a pioneer in vegetarian capsule manufacturing in India and is the second-largest domestic producer of gelatin capsules. It operates within the pharmaceutical and dietary supplement sectors but does not have listed subsidiaries or public exchange listings.
This page is a live market overview for NATURAL CAPSULES LIMITED (NATCAPSUQ) on the NSE. As a listed security, NATURAL CAPSULES LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for NATCAPSUQ before placing trades on tick2trade.
As of the latest feed, NATCAPSUQ last traded at ₹155.04 on NSE, up ₹5.13 (3.42%) from the previous close of ₹149.91. Today's session range is ₹150.98 – ₹157.97, against a 52-week band of ₹136.36 – ₹296. Traded volume today stands at 54.71K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for NATCAPSUQ in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether NATCAPSUQ is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for NATURAL CAPSULES LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in NATCAPSUQ. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated NATCAPSUQ option chain page linked from this overview.
| Results - FY26 |
| To consider and approve the financial results for the period ended March 31, 2026 |
| 27 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 and other business matters | 13 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 and other business matters | 13 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 4 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and other business matters | 29 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.